Drugmaker Novartis has named Indian-origin Vasant Narasimhan as CEO effective February 1, 2018. He will replace Joseph Jimenez, who said, “I’ve been CEO for eight years and I’ve been pretty public about the fact that I didn’t think a CEO should stay much longer." "[Y]ou see what you want to change, you change it, and then...pass it on," Jimenez added.